HHS Secretary Mike Leavitt expects to finalize a memorandum of understanding for drug and medical device safety during his trip to China the week of Dec. 10, but the agreement will not include plans to establish a permanent FDA office in China
Join thousands of industry professionals who rely on Scrip for daily insights
Already a subscriber?
After in-licensing a cardiovascular candidate last year, AstraZeneca has signed a strategic drug discovery alliance, which could generate billions of dollars in payments to the Chinese firm.
Recent moves in the industry include changes at the top at iOnctura and Orca Bio, plus Sutro Biopharma, Tenpoint Therapeutics and Helix BioPharma get new CFOs.
Study to add to safety and tolerability data for infused formulation and may help identify optimal dose for future pivotal trial.
